| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | structural constituent of postsynaptic actin cytoskeleton | 3.77e-06 | 11 | 58 | 3 | GO:0098973 | |
| GeneOntologyMolecularFunction | structural constituent of postsynapse | 1.09e-04 | 32 | 58 | 3 | GO:0099186 | |
| GeneOntologyMolecularFunction | structural constituent of synapse | 2.46e-04 | 42 | 58 | 3 | GO:0098918 | |
| GeneOntologyMolecularFunction | armadillo repeat domain binding | 2.95e-04 | 9 | 58 | 2 | GO:0070016 | |
| GeneOntologyMolecularFunction | histone binding | 1.02e-03 | 265 | 58 | 5 | GO:0042393 | |
| GeneOntologyBiologicalProcess | neuroblast division | 1.09e-05 | 16 | 57 | 3 | GO:0055057 | |
| GeneOntologyBiologicalProcess | cell junction organization | POTEE DST MYCBP2 POTEF PCDHB9 GJC1 C3 SPARCL1 POTEI SLITRK6 PATJ | 6.16e-05 | 974 | 57 | 11 | GO:0034330 |
| GeneOntologyBiologicalProcess | formation of radial glial scaffolds | 7.46e-05 | 5 | 57 | 2 | GO:0021943 | |
| GeneOntologyBiologicalProcess | postsynaptic actin cytoskeleton organization | 8.51e-05 | 31 | 57 | 3 | GO:0098974 | |
| GeneOntologyBiologicalProcess | postsynaptic cytoskeleton organization | 1.23e-04 | 35 | 57 | 3 | GO:0099188 | |
| GeneOntologyCellularComponent | NuA4 histone acetyltransferase complex | 9.50e-05 | 32 | 58 | 3 | GO:0035267 | |
| GeneOntologyCellularComponent | H4/H2A histone acetyltransferase complex | 9.50e-05 | 32 | 58 | 3 | GO:0043189 | |
| GeneOntologyCellularComponent | H4 histone acetyltransferase complex | 2.65e-04 | 45 | 58 | 3 | GO:1902562 | |
| Domain | Actin_CS | 1.47e-05 | 16 | 57 | 3 | IPR004001 | |
| Domain | ACTINS_2 | 1.78e-05 | 17 | 57 | 3 | PS00432 | |
| Domain | Actin/actin-like_CS | 2.13e-05 | 18 | 57 | 3 | IPR020902 | |
| Domain | ACTINS_ACT_LIKE | 2.52e-05 | 19 | 57 | 3 | PS01132 | |
| Domain | Actin | 1.14e-04 | 31 | 57 | 3 | IPR004000 | |
| Domain | Actin | 1.14e-04 | 31 | 57 | 3 | PF00022 | |
| Domain | ACTIN | 1.14e-04 | 31 | 57 | 3 | SM00268 | |
| Domain | Cadherin_C | 2.84e-04 | 42 | 57 | 3 | IPR032455 | |
| Domain | Cadherin_C_2 | 2.84e-04 | 42 | 57 | 3 | PF16492 | |
| Domain | Ank | 6.48e-04 | 228 | 57 | 5 | PF00023 | |
| Domain | - | 9.46e-04 | 248 | 57 | 5 | 1.25.40.20 | |
| Domain | ANK | 9.98e-04 | 251 | 57 | 5 | SM00248 | |
| Domain | Cadherin_2 | 1.03e-03 | 65 | 57 | 3 | PF08266 | |
| Domain | Cadherin_N | 1.03e-03 | 65 | 57 | 3 | IPR013164 | |
| Domain | ANK_REPEAT | 1.03e-03 | 253 | 57 | 5 | PS50088 | |
| Domain | Ankyrin_rpt-contain_dom | 1.05e-03 | 254 | 57 | 5 | IPR020683 | |
| Domain | ANK_REP_REGION | 1.05e-03 | 254 | 57 | 5 | PS50297 | |
| Domain | Ankyrin_rpt | 1.21e-03 | 262 | 57 | 5 | IPR002110 | |
| Domain | G_patch | 2.22e-03 | 23 | 57 | 2 | SM00443 | |
| Domain | G_patch_dom | 2.22e-03 | 23 | 57 | 2 | IPR000467 | |
| Domain | G_PATCH | 2.22e-03 | 23 | 57 | 2 | PS50174 | |
| Domain | G-patch | 2.22e-03 | 23 | 57 | 2 | PF01585 | |
| Domain | tRNA-bd_arm | 2.42e-03 | 24 | 57 | 2 | IPR010978 | |
| Domain | SANT_dom | 2.84e-03 | 26 | 57 | 2 | IPR017884 | |
| Domain | SANT | 3.29e-03 | 28 | 57 | 2 | PS51293 | |
| Domain | Ank_2 | 4.19e-03 | 215 | 57 | 4 | PF12796 | |
| Domain | Cadherin_CS | 4.50e-03 | 109 | 57 | 3 | IPR020894 | |
| Domain | CADHERIN_1 | 4.98e-03 | 113 | 57 | 3 | PS00232 | |
| Domain | Cadherin | 4.98e-03 | 113 | 57 | 3 | PF00028 | |
| Domain | CADHERIN_2 | 5.10e-03 | 114 | 57 | 3 | PS50268 | |
| Domain | - | 5.10e-03 | 114 | 57 | 3 | 2.60.40.60 | |
| Domain | Myb_DNA-binding | 5.10e-03 | 35 | 57 | 2 | PF00249 | |
| Domain | CA | 5.23e-03 | 115 | 57 | 3 | SM00112 | |
| Domain | Cadherin-like | 5.35e-03 | 116 | 57 | 3 | IPR015919 | |
| Domain | Cadherin | 5.61e-03 | 118 | 57 | 3 | IPR002126 | |
| Domain | Cadherin_tail | 5.69e-03 | 37 | 57 | 2 | PF15974 | |
| Domain | Cadherin_CBD | 5.69e-03 | 37 | 57 | 2 | IPR031904 | |
| Domain | MYB_LIKE | 6.00e-03 | 38 | 57 | 2 | PS50090 | |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | 4.45e-08 | 588 | 58 | 10 | 38580884 | |
| Pubmed | 3.67e-07 | 9 | 58 | 3 | 16364570 | ||
| Pubmed | Identification of a novel actin isoform in hepatocellular carcinoma. | 1.97e-06 | 15 | 58 | 3 | 16824795 | |
| Pubmed | A primate-specific POTE-actin fusion protein plays a role in apoptosis. | 2.73e-06 | 2 | 58 | 2 | 19669888 | |
| Pubmed | 2.73e-06 | 2 | 58 | 2 | 21519849 | ||
| Pubmed | 6.02e-06 | 591 | 58 | 8 | 15231748 | ||
| Pubmed | Differential modulation of TCF/LEF-1 activity by the soluble LRP6-ICD. | 8.19e-06 | 3 | 58 | 2 | 20676368 | |
| Pubmed | Evolution and expression of chimeric POTE-actin genes in the human genome. | 8.19e-06 | 3 | 58 | 2 | 17101985 | |
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | 8.53e-06 | 440 | 58 | 7 | 34244565 | |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | 1.10e-05 | 1082 | 58 | 10 | 38697112 | |
| Pubmed | 1.24e-05 | 653 | 58 | 8 | 22586326 | ||
| Pubmed | 1.64e-05 | 4 | 58 | 2 | 10395741 | ||
| Pubmed | 1.64e-05 | 4 | 58 | 2 | 12139968 | ||
| Pubmed | 2.06e-05 | 96 | 58 | 4 | 23580065 | ||
| Pubmed | NCOR2 MYCBP2 NAT10 DDX42 AKNA GOLIM4 DAAM1 KIR2DL4 ARHGAP45 CNOT1 | 2.12e-05 | 1168 | 58 | 10 | 19946888 | |
| Pubmed | 2.54e-05 | 34 | 58 | 3 | 26120030 | ||
| Pubmed | CRB2 completes a fully expressed Crumbs complex in the Retinal Pigment Epithelium. | 2.72e-05 | 5 | 58 | 2 | 26404741 | |
| Pubmed | LRP6 acts as a scaffold protein in cardiac gap junction assembly. | 2.72e-05 | 5 | 58 | 2 | 27250245 | |
| Pubmed | 3.34e-05 | 750 | 58 | 8 | 11230166 | ||
| Pubmed | 4.08e-05 | 6 | 58 | 2 | 20123964 | ||
| Pubmed | 4.08e-05 | 6 | 58 | 2 | 37091972 | ||
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | 5.09e-05 | 582 | 58 | 7 | 20467437 | |
| Pubmed | 5.64e-05 | 1049 | 58 | 9 | 27880917 | ||
| Pubmed | 5.71e-05 | 7 | 58 | 2 | 15276201 | ||
| Pubmed | 6.77e-05 | 47 | 58 | 3 | 18351675 | ||
| Pubmed | 6.94e-05 | 418 | 58 | 6 | 34709266 | ||
| Pubmed | WSTF acetylation by MOF promotes WSTF activities and oncogenic functions. | 7.60e-05 | 8 | 58 | 2 | 32518374 | |
| Pubmed | 7.60e-05 | 8 | 58 | 2 | 8661102 | ||
| Pubmed | Unbiased Identification of trans Regulators of ADAR and A-to-I RNA Editing. | 9.05e-05 | 271 | 58 | 5 | 32433965 | |
| Pubmed | 9.77e-05 | 9 | 58 | 2 | 11084652 | ||
| Pubmed | 1.12e-04 | 660 | 58 | 7 | 32780723 | ||
| Pubmed | 1.15e-04 | 149 | 58 | 4 | 22664934 | ||
| Pubmed | Clustered gamma-protocadherins regulate cortical interneuron programmed cell death. | 1.21e-04 | 57 | 58 | 3 | 32633719 | |
| Pubmed | HIF-dependent hematopoietic factors regulate the development of the embryonic vasculature. | 1.22e-04 | 10 | 58 | 2 | 16824955 | |
| Pubmed | 1.22e-04 | 10 | 58 | 2 | 14715945 | ||
| Pubmed | 1.24e-04 | 1442 | 58 | 10 | 35575683 | ||
| Pubmed | 1.49e-04 | 11 | 58 | 2 | 31045206 | ||
| Pubmed | A forward genetic screen in mice identifies mutants with abnormal cortical patterning. | 1.49e-04 | 11 | 58 | 2 | 23968836 | |
| Pubmed | The role of microtubule actin cross-linking factor 1 (MACF1) in the Wnt signaling pathway. | 1.49e-04 | 11 | 58 | 2 | 16815997 | |
| Pubmed | 1.49e-04 | 11 | 58 | 2 | 24800743 | ||
| Pubmed | 1.62e-04 | 163 | 58 | 4 | 24316575 | ||
| Pubmed | 1.68e-04 | 1497 | 58 | 10 | 31527615 | ||
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | 1.78e-04 | 497 | 58 | 6 | 36774506 | |
| Pubmed | Requirement of the MADS-box transcription factor MEF2C for vascular development. | 1.78e-04 | 12 | 58 | 2 | 9778514 | |
| Pubmed | Molecular dynamics of Dkk4 modulates Wnt action and regulates meibomian gland development. | 1.78e-04 | 12 | 58 | 2 | 27864382 | |
| Pubmed | Lrp6-mediated canonical Wnt signaling is required for lip formation and fusion. | 1.78e-04 | 12 | 58 | 2 | 19700620 | |
| Pubmed | Comparative DNA sequence analysis of mouse and human protocadherin gene clusters. | 2.04e-04 | 68 | 58 | 3 | 11230163 | |
| Pubmed | Mutation specific functions of EGFR result in a mutation-specific downstream pathway activation. | 2.04e-04 | 68 | 58 | 3 | 25754235 | |
| Pubmed | The basic helix-loop-helix transcription factor, dHAND, is required for vascular development. | 2.11e-04 | 13 | 58 | 2 | 10675351 | |
| Pubmed | 2.11e-04 | 13 | 58 | 2 | 16510874 | ||
| Pubmed | A striking organization of a large family of human neural cadherin-like cell adhesion genes. | 2.42e-04 | 72 | 58 | 3 | 10380929 | |
| Pubmed | 2.46e-04 | 14 | 58 | 2 | 19015224 | ||
| Pubmed | 2.49e-04 | 529 | 58 | 6 | 14621295 | ||
| Pubmed | Cadherin superfamily genes: functions, genomic organization, and neurologic diversity. | 2.62e-04 | 74 | 58 | 3 | 10817752 | |
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | 2.62e-04 | 759 | 58 | 7 | 35915203 | |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | 2.74e-04 | 1294 | 58 | 9 | 30804502 | |
| Pubmed | 2.83e-04 | 15 | 58 | 2 | 16510875 | ||
| Pubmed | 2.83e-04 | 15 | 58 | 2 | 23515096 | ||
| Pubmed | R-spondin 2 is required for normal laryngeal-tracheal, lung and limb morphogenesis. | 2.83e-04 | 15 | 58 | 2 | 18256198 | |
| Pubmed | 2.95e-04 | 77 | 58 | 3 | 10835267 | ||
| Pubmed | 3.04e-04 | 549 | 58 | 6 | 38280479 | ||
| Pubmed | Filamin A- and formin 2-dependent endocytosis regulates proliferation via the canonical Wnt pathway. | 3.23e-04 | 16 | 58 | 2 | 27789627 | |
| Pubmed | MKRN2 Physically Interacts with GLE1 to Regulate mRNA Export and Zebrafish Retinal Development. | 3.29e-04 | 358 | 58 | 5 | 32460013 | |
| Pubmed | Large exons encoding multiple ectodomains are a characteristic feature of protocadherin genes. | 3.30e-04 | 80 | 58 | 3 | 10716726 | |
| Pubmed | 3.66e-04 | 17 | 58 | 2 | 20724449 | ||
| Pubmed | beta-Catenin controls hair follicle morphogenesis and stem cell differentiation in the skin. | 3.66e-04 | 17 | 58 | 2 | 11371349 | |
| Pubmed | Mesenchymal Wnt signaling promotes formation of sternum and thoracic body wall. | 3.66e-04 | 17 | 58 | 2 | 25727890 | |
| Pubmed | 3.67e-04 | 202 | 58 | 4 | 24639526 | ||
| Pubmed | 4.08e-04 | 86 | 58 | 3 | 37253089 | ||
| Pubmed | The deubiquitinase TRABID stabilizes the K29/K48-specific E3 ubiquitin ligase HECTD1. | 4.40e-04 | 212 | 58 | 4 | 33853758 | |
| Pubmed | 4.59e-04 | 19 | 58 | 2 | 15184386 | ||
| Pubmed | 4.66e-04 | 90 | 58 | 3 | 19515997 | ||
| Pubmed | 4.96e-04 | 844 | 58 | 7 | 25963833 | ||
| Pubmed | Scanning the human proteome for calmodulin-binding proteins. | 4.97e-04 | 92 | 58 | 3 | 15840729 | |
| Pubmed | TRIM33 drives prostate tumor growth by stabilizing androgen receptor from Skp2-mediated degradation. | 5.06e-04 | 220 | 58 | 4 | 35785414 | |
| Pubmed | Wntless is required for peripheral lung differentiation and pulmonary vascular development. | 5.09e-04 | 20 | 58 | 2 | 23523683 | |
| Pubmed | 5.09e-04 | 20 | 58 | 2 | 16920270 | ||
| Pubmed | 5.50e-04 | 225 | 58 | 4 | 12168954 | ||
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | 5.58e-04 | 861 | 58 | 7 | 36931259 | |
| Pubmed | The transcription factor Maz is essential for normal eye development. | 5.62e-04 | 21 | 58 | 2 | 32571845 | |
| Pubmed | Snf2h Drives Chromatin Remodeling to Prime Upper Layer Cortical Neuron Development. | 5.62e-04 | 21 | 58 | 2 | 31680852 | |
| Pubmed | 5.62e-04 | 21 | 58 | 2 | 24923560 | ||
| Pubmed | 5.64e-04 | 1429 | 58 | 9 | 35140242 | ||
| Pubmed | 6.16e-04 | 99 | 58 | 3 | 19730683 | ||
| Pubmed | 6.18e-04 | 22 | 58 | 2 | 23658188 | ||
| Pubmed | LASP-1: a nuclear hub for the UHRF1-DNMT1-G9a-Snail1 complex. | 6.18e-04 | 22 | 58 | 2 | 25982273 | |
| Pubmed | MEIS-WNT5A axis regulates development of fourth ventricle choroid plexus. | 6.18e-04 | 22 | 58 | 2 | 34032267 | |
| Pubmed | An atlas of combinatorial transcriptional regulation in mouse and man. | 6.22e-04 | 877 | 58 | 7 | 20211142 | |
| Pubmed | 6.37e-04 | 234 | 58 | 4 | 36243803 | ||
| Pubmed | 6.49e-04 | 634 | 58 | 6 | 34591612 | ||
| Pubmed | Cytokinesis involves a nontranscriptional function of the Hippo pathway effector YAP. | 6.76e-04 | 23 | 58 | 2 | 26933062 | |
| Pubmed | 7.37e-04 | 24 | 58 | 2 | 21991325 | ||
| Pubmed | 7.51e-04 | 652 | 58 | 6 | 31180492 | ||
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | 7.56e-04 | 1489 | 58 | 9 | 28611215 | |
| Pubmed | PROTAC-mediated degradation reveals a non-catalytic function of AURORA-A kinase. | 7.80e-04 | 247 | 58 | 4 | 32989298 | |
| Pubmed | Atrx deficiency induces telomere dysfunction, endocrine defects, and reduced life span. | 8.00e-04 | 25 | 58 | 2 | 23563309 | |
| Pubmed | Complementary proteomics strategies capture an ataxin-1 interactome in Neuro-2a cells. | 8.32e-04 | 665 | 58 | 6 | 30457570 | |
| Pubmed | Deficiency of Wdr60 and Wdr34 cause distinct neural tube malformation phenotypes in early embryos. | 8.66e-04 | 26 | 58 | 2 | 37228654 | |
| Pubmed | DAAM1 and DAAM2 are co-required for myocardial maturation and sarcomere assembly. | 8.66e-04 | 26 | 58 | 2 | 26526197 | |
| Pubmed | 8.89e-04 | 446 | 58 | 5 | 24255178 | ||
| Interaction | ACTG2 interactions | 1.19e-05 | 49 | 58 | 4 | int:ACTG2 | |
| Cytoband | 2q21.1 | 5.62e-05 | 58 | 58 | 3 | 2q21.1 | |
| Cytoband | 5q31 | 4.27e-04 | 115 | 58 | 3 | 5q31 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr2q21 | 9.43e-04 | 151 | 58 | 3 | chr2q21 | |
| GeneFamily | Ankyrin repeat domain containing|POTE ankyrin domain containing | 1.60e-08 | 13 | 41 | 4 | 685 | |
| GeneFamily | Ankyrin repeat domain containing | 2.08e-04 | 242 | 41 | 5 | 403 | |
| GeneFamily | Clustered protocadherins | 4.10e-04 | 64 | 41 | 3 | 20 | |
| GeneFamily | G-patch domain containing|Minor histocompatibility antigens | 1.13e-03 | 22 | 41 | 2 | 579 | |
| GeneFamily | GATA zinc finger domain containing|Myb/SANT domain containing | 6.43e-03 | 53 | 41 | 2 | 532 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_500_k-means-cluster#3 | 4.12e-06 | 255 | 55 | 7 | Facebase_RNAseq_e10.5_Maxillary Arch_500_K3 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_G2M|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.09e-07 | 175 | 58 | 6 | 3e56695a9db97cb1d3503425c48eb79bbf99213e | |
| ToppCell | Fetal_29-31_weeks-Immune-T_lymphocyte-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.88e-07 | 192 | 58 | 6 | 92f141d5ac462f652f405efa73ac6ef751f40ea3 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.06e-07 | 195 | 58 | 6 | 5c86fddd6d0530beecf45ea5ba6b823123847696 | |
| ToppCell | NS-control-d_0-4-Epithelial-Secretory|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.32e-07 | 199 | 58 | 6 | 32bdfff40fd442b88489c8b0f79af3927a51a03c | |
| ToppCell | control-Epithelial-Secretory|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.32e-07 | 199 | 58 | 6 | 3d01f90ffd271ca00129192787e4921bdca7e01e | |
| ToppCell | control-Epithelial-Secretory|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.32e-07 | 199 | 58 | 6 | 262e5b8a52c8ddb0b47048c786e8bdb7158e1b9a | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD8_c01-LEF1|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.86e-06 | 156 | 58 | 5 | 7569cab30caafcb273e8ef0b73c9e1bf87076984 | |
| ToppCell | droplet-Liver-LIVER_NPC-30m-Lymphocytic-NK_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.67e-06 | 168 | 58 | 5 | 110c3c7c322e04a684a19c2b5434a502279fd000 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Lymphoid-CD4/CD8-CD8_cytotoxic-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.67e-06 | 168 | 58 | 5 | 50991eb794742592a0c96cd9a72460ab339e74ff | |
| ToppCell | droplet-Liver-LIVER_NPC-30m-Lymphocytic-NK/T|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.67e-06 | 168 | 58 | 5 | 735d30cfda1889740bdeb43e39330a52e8f4d599 | |
| ToppCell | droplet-Liver-LIVER_NPC-30m-Lymphocytic|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.83e-06 | 170 | 58 | 5 | 26178277bf9c7f2f06b5c0b03d4b69d78e9580c4 | |
| ToppCell | droplet-Liver-LIVER-NPC-1m-Lymphocytic-macrophage/monocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.83e-06 | 170 | 58 | 5 | 3ad9f950b87ee98f025ab9b4a8ed551e6a9b4764 | |
| ToppCell | severe-B_memory|severe / disease stage, cell group and cell class | 3.08e-06 | 173 | 58 | 5 | 3a987ac53a0136cc4c70ce8b901a15fc00c795e1 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Lymphocytic_T/NK|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.39e-06 | 186 | 58 | 5 | 9d576dce2c5deefef1adda16c6da7055c8d57f8f | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Lymphocytic_T/NK-T_Cell-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.39e-06 | 186 | 58 | 5 | bd3bd022b575d9b0ef90d50a5cb874085a827b77 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Lymphocytic_T/NK-T_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.39e-06 | 186 | 58 | 5 | 924cc357b4c4ce8e9b05773bdab544f0b65474cc | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Hematopoietic-T_cells-gdT|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.87e-06 | 190 | 58 | 5 | 116314a27064d3005d950c9a9163b79ea438707b | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Lymphocytic_T/NK-T_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.87e-06 | 190 | 58 | 5 | 07ea0578ca0561077557203ae660530f53fc4067 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Immune-Lymphocytic_T/NK|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.87e-06 | 190 | 58 | 5 | b772a5d281fe016f259ddda80d6f33d949dcac2b | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Lymphocytic_T/NK-T_Cell-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.87e-06 | 190 | 58 | 5 | 5b4b3eed7aa798bb7e3c5e968c8dc4144e377a5f | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Immune-Lymphocytic_T/NK|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.99e-06 | 191 | 58 | 5 | d9506b88d806aadd4c2b9bf86fe994c47799e7f6 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Immune-Lymphocytic_T/NK-T_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.99e-06 | 191 | 58 | 5 | b42c54308abe1241cc38ddce96b9d38d07983891 | |
| ToppCell | COVID-19-lung-CD4+_Treg|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.99e-06 | 191 | 58 | 5 | 5a4ad5ae5c2dbfb225158cb598ef649c26a48350 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-CD4/CD8-Prolif_T-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.99e-06 | 191 | 58 | 5 | 912e2d10d3423aa7f708fcf2b11da1845f12d7d3 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Immune-Lymphocytic_T/NK-T_Cell-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.99e-06 | 191 | 58 | 5 | 1a2d5fec2bea96da2154b0aed252f1bb35102f6e | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-CD4/CD8-Prolif_T|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.99e-06 | 191 | 58 | 5 | 77a2746b6d9c53b08d4405411c16fcc5a6c734ce | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Immune-Lymphocytic_T/NK-T_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.99e-06 | 191 | 58 | 5 | 326b4541069efedc8ab409f85bb11f77346dda90 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Immune-Lymphocytic_T/NK-T_Cell-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.99e-06 | 191 | 58 | 5 | 9aabbc65430e2233b8f2d3fff9face7807b88b48 | |
| ToppCell | Fetal_29-31_weeks-Immune-T_lymphocyte|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 5.12e-06 | 192 | 58 | 5 | 69a2b04f03a1b82d067018379f7b8a116e954040 | |
| ToppCell | Healthy_Control-Lymphoid-T-CD8_T|Healthy_Control / Condition, Lineage, Cell class and cell subclass | 5.12e-06 | 192 | 58 | 5 | 36b6ea21b0b1342f2dcac4dcaf359b6c772203f7 | |
| ToppCell | COVID-19-lung-CD4+_T_cells_metabolically_active|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.25e-06 | 193 | 58 | 5 | 326fd2ce2c4b51e5a38f2a7a09f22f8f0e92735a | |
| ToppCell | Healthy/Control-CD4+_T_naive|Healthy/Control / Disease group and Cell class | 5.25e-06 | 193 | 58 | 5 | f5face746df3517c86d72e31ba8f1b78c4c6b481 | |
| ToppCell | Healthy/Control-CD4+_T_naive|World / Disease group and Cell class | 5.25e-06 | 193 | 58 | 5 | 6218e6cbe44d92bb98d42ef2f5e18ab7a683b100 | |
| ToppCell | COVID-19-kidney-T-cells-1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.25e-06 | 193 | 58 | 5 | 5b84fa640cf30dea55fde53b810f850ff946d253 | |
| ToppCell | Healthy_donor-CD4+_T_naive|World / disease group, cell group and cell class (v2) | 5.39e-06 | 194 | 58 | 5 | bcaaa6b6ce5b3552f11311d8ee91c35b8ec065f8 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Immune|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.39e-06 | 194 | 58 | 5 | 4dfc890bacf133cfb6ec7c8b73f084f2491cf78e | |
| ToppCell | Immune-T_lymphocyte|World / Lineage, Cell type, age group and donor | 5.39e-06 | 194 | 58 | 5 | f47fa18c87b35a3960557f8169ff7830dd6ecb80 | |
| ToppCell | COVID-19-lung-CD4+_T_cells_metabolically_active|lung / Disease (COVID-19 only), tissue and cell type | 5.39e-06 | 194 | 58 | 5 | 2a144a1c2d537c8a59aa419206ddd96c23f0aeab | |
| ToppCell | background-T_cells|background / Sample and Cell Type and Tumor Cluster (all cells) | 5.66e-06 | 196 | 58 | 5 | b60db71f419caf3705e391e7b6dcf29b406cda9a | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-PMP-PMP_G2M|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.81e-06 | 197 | 58 | 5 | 29b0a5927f80455eef7b793feabef69fba1a3df1 | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-PMP|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.95e-06 | 198 | 58 | 5 | 148f5fee19ea8dff7f2de4ca69c3b03e5221985d | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 6.10e-06 | 199 | 58 | 5 | 30d3e8c0681ec11f86dd38c5f48d21187a1b4f90 | |
| ToppCell | Control_saline-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|Control_saline / Treatment groups by lineage, cell group, cell type | 6.25e-06 | 200 | 58 | 5 | bd8cf33502adea320e91ca2af14e1911d88ad374 | |
| ToppCell | severe_COVID-19-Treg|World / disease group, cell group and cell class (v2) | 3.53e-05 | 142 | 58 | 4 | cccc2e738eeca342cd937c4cd863571951b2257e | |
| ToppCell | Lymphoid-T_cells_(cycle)|World / shred on cell class and cell subclass (v4) | 3.63e-05 | 143 | 58 | 4 | 2fbcca395971a8452f68481282a74cec4005d1e2 | |
| ToppCell | severe_COVID-19-Treg|severe_COVID-19 / disease group, cell group and cell class (v2) | 4.49e-05 | 151 | 58 | 4 | bef8f31d5c4345a346fcf15db0fa36265ac304e7 | |
| ToppCell | Basal_cells-Donor_02|World / lung cells shred on cell class, cell subclass, sample id | 4.61e-05 | 152 | 58 | 4 | 72499e4d2b374ef5f1621c89d94727ecf4bd4d5d | |
| ToppCell | droplet-Liver-LIVER_NPC-30m|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.49e-05 | 159 | 58 | 4 | 997963d879e5819683793cddf5e1acff1b81a1b8 | |
| ToppCell | droplet-Liver-LIVER_NPC|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.49e-05 | 159 | 58 | 4 | e4eaa88772835d6b78e1a18a0cec52de51e80339 | |
| ToppCell | tumor_Lung-T/NK_cells-Naive_CD8+_T|tumor_Lung / Location, Cell class and cell subclass | 6.19e-05 | 164 | 58 | 4 | a669d3b39dcd219a1973e266765e2f2b114438ef | |
| ToppCell | facs-MAT-Fat-24m-Lymphocytic-CD4-positive,_alpha-beta_T_cell|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.19e-05 | 164 | 58 | 4 | e9e34c305c943675688e54ab331c2bdefb2fac68 | |
| ToppCell | PND10-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-CD4_T-CD4_T_G2M|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.49e-05 | 166 | 58 | 4 | a41a20cef053c67da2d435e3e132ce28f1661c03 | |
| ToppCell | facs-GAT-Fat-3m-Lymphocytic-CD8-positive,_alpha-beta_T_cell|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.49e-05 | 166 | 58 | 4 | 3695407e4638f3c18fbff63daba52baa9256c429 | |
| ToppCell | mild_COVID-19_(asymptomatic)-CD4+_T_naive|mild_COVID-19_(asymptomatic) / disease group, cell group and cell class (v2) | 6.64e-05 | 167 | 58 | 4 | 78d264af390bd89942ffbb2991dc94f50756d4c9 | |
| ToppCell | facs-Lung-18m-Hematologic-lymphocytic-regulatory_T_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.80e-05 | 168 | 58 | 4 | 2d2eab3190374f79f373e31c8b062ff4e1766396 | |
| ToppCell | facs-Lung-18m-Hematologic-lymphocytic-regulatory_T_cell-regulatory_T_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.80e-05 | 168 | 58 | 4 | df58156721457b34af1e81c0eb8a7243cbbfb303 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.80e-05 | 168 | 58 | 4 | 315ca578c945aeeb77acda2727f3e6db8b43f43e | |
| ToppCell | droplet-Thymus-nan-18m-Lymphocytic-DN4_thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.12e-05 | 170 | 58 | 4 | 90f7640f04672c800cb28aea50004b1bb0565e8a | |
| ToppCell | facs-Lung-Endomucin-24m-Lymphocytic-T_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.12e-05 | 170 | 58 | 4 | 2b5b1f8d13b9806b76b44a53f47a23dd9ff09808 | |
| ToppCell | facs-Lung-Endomucin-24m-Lymphocytic-Ly6g5b+_T|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.12e-05 | 170 | 58 | 4 | 43c48267d8291c88263148a36fbb63c27f0e4f1c | |
| ToppCell | Bronchial_Brush-Immune-B_cells|Immune / Tissue, Lineage and Cell class of Lung Cells from 10X | 7.12e-05 | 170 | 58 | 4 | 53e9372cb06a2dc5c8ecb3f9af42f3c23da96431 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Basal_resting-Basal_resting_L.0.0.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.28e-05 | 171 | 58 | 4 | ea60d9e9df28ab991fbdb596784b44f6a9fc5827 | |
| ToppCell | facs-Marrow-T-cells-3m-Lymphocytic-CD4-positive,_alpha-beta_T_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.28e-05 | 171 | 58 | 4 | 8719a18c9e6b6f5d8ec4e937c2bda1e36441c9ec | |
| ToppCell | facs-Marrow-T-cells-3m-Lymphocytic-BM_CD4_T_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.28e-05 | 171 | 58 | 4 | f4cdd7862c8fe99ee765a2f3ed375b584f4976c5 | |
| ToppCell | 390C-Endothelial_cells-Endothelial-C_(Capillary_Aerocyte_)|390C / Donor, Lineage, Cell class and subclass (all cells) | 7.45e-05 | 172 | 58 | 4 | 6f302ed795767a9636081dc64373f8f039ea16d2 | |
| ToppCell | facs-GAT-Fat-24m-Lymphocytic-CD8-positive,_alpha-beta_T_cell|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.45e-05 | 172 | 58 | 4 | a9f0ccaca0d83bfec79e3251e346a165c34c242b | |
| ToppCell | facs-Lung-nan-3m-Lymphocytic|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.45e-05 | 172 | 58 | 4 | 7af0713c40ea48f1e92c859c4fc4d8f0137c4415 | |
| ToppCell | 390C-Endothelial_cells-Endothelial-C_(Capillary_Aerocyte_)-|390C / Donor, Lineage, Cell class and subclass (all cells) | 7.45e-05 | 172 | 58 | 4 | fd8097299fc05390b30afaa9e6c80b1f607c27aa | |
| ToppCell | facs-Lung-EPCAM-18m-Lymphocytic-Regulatory_T|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.62e-05 | 173 | 58 | 4 | 82fa5ff6a00216a21a37fafeaf3e21e964c61d47 | |
| ToppCell | facs-Lung-EPCAM-18m-Lymphocytic-regulatory_T_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.62e-05 | 173 | 58 | 4 | 13f67f61edb734ff846da92d41e81ec4670a2b66 | |
| ToppCell | ILEUM-inflamed-(1)_T_(gd)|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 7.62e-05 | 173 | 58 | 4 | 85c3e227c81c6ab70148639381389fba3ac5e088 | |
| ToppCell | TCGA-Brain-Primary_Tumor-Glioblastoma-Primary_GBM-11|TCGA-Brain / Sample_Type by Project: Shred V9 | 7.64e-05 | 63 | 58 | 3 | d7dc1356a60cb527fe668328d5375f352239d911 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-NK_cell-NK_CD56bright-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 7.96e-05 | 175 | 58 | 4 | 0ed053aa8353c72ff37fee830672704a3ddc7d85 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-NK_cell-NK_CD56bright|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 7.96e-05 | 175 | 58 | 4 | 0124a3c4696b39cee8b566e94603d1d3d128bfa5 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-NK_cell-NK_CD56bright|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.96e-05 | 175 | 58 | 4 | e219b61d6bc078d44ea7d06191d3462654d857a1 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-NK_cell-NK_CD56bright-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.96e-05 | 175 | 58 | 4 | bd16c80418bf71127e6f1e50edf83967c9218b42 | |
| ToppCell | PND10-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-Treg-Treg_G2M|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.96e-05 | 175 | 58 | 4 | 9de288c338cee67be0e9b836c87799bbc1db1c38 | |
| ToppCell | facs-MAT-Fat-3m-Lymphocytic-CD8-positive,_alpha-beta_T_cell|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.14e-05 | 176 | 58 | 4 | 77c6103639acd0f3d6a2171c5f37a8083b6c2cf0 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.32e-05 | 177 | 58 | 4 | 64b8f665fdaf975558af2ad7d9b54d206de8350c | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Lymphocytic-T_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.32e-05 | 177 | 58 | 4 | 36da06ca9577cdb7c7b5114e604f6546b9765c08 | |
| ToppCell | facs-MAT-Fat-3m-Lymphocytic-CD4-positive,_alpha-beta_T_cell|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.32e-05 | 177 | 58 | 4 | b5c20c1247f11ebc97e9cb47482564cd74e36ca6 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.51e-05 | 178 | 58 | 4 | 01dafd19de04eff459253eaa9a35debf8f3deedf | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD8_c01-LEF1|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.51e-05 | 178 | 58 | 4 | 73936c2e7e8855b4ab65cad425686513dba331a3 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Hematologic-hematopoietic_stem_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.51e-05 | 178 | 58 | 4 | d9eba884e18a0c89bdc70c194bfe4d62cca164fa | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Hematologic-hematopoietic_stem_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.51e-05 | 178 | 58 | 4 | b03aa1de9d20895ebad55f6fcd6fe7a49335db5a | |
| ToppCell | droplet-Marrow-nan-3m-Hematologic-hematopoietic_precursor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.51e-05 | 178 | 58 | 4 | 8aef208b6351143562c87715bb11628880abce94 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Hematologic|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.51e-05 | 178 | 58 | 4 | 0f5cf34609df791c8baebfdc6590f6eb4dbe0509 | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_G2M|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.51e-05 | 178 | 58 | 4 | c87945146b2734141f07b39d268e0d8086ee0364 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Immune-Lymphocytic_T/NK-Natural_Killer_Cell_/_Natural_Killer_T_Cell-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.88e-05 | 180 | 58 | 4 | bb2dbf7ed03d5ac765635b7afe738efa822841d0 | |
| ToppCell | Adult-Immune-T_lymphocyte-D122|Adult / Lineage, Cell type, age group and donor | 8.88e-05 | 180 | 58 | 4 | 06c371d0f0c5a7b234dd143e98800e19af95a8b5 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Immune-Lymphocytic_T/NK-Natural_Killer_Cell_/_Natural_Killer_T_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.88e-05 | 180 | 58 | 4 | c62417f205bcbf3b212ae177f63562ec6467c855 | |
| ToppCell | COVID-19-kidney-NK|COVID-19 / Disease (COVID-19 only), tissue and cell type | 9.07e-05 | 181 | 58 | 4 | 8906ee8a7a1616dfe8c3b5c73988416641213629 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_NK-NK_bright-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 9.07e-05 | 181 | 58 | 4 | 9c4f9abb9335da2b07644bca8faff1baa1bb9f5b | |
| ToppCell | RA-17._Lymphocyte|RA / Chamber and Cluster_Paper | 9.27e-05 | 182 | 58 | 4 | 257a7847917b6ea1d60608183d90300bfd028758 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 9.27e-05 | 182 | 58 | 4 | 1aea96ee211f7b9caef7fd385233f51be6021a73 | |
| ToppCell | droplet-Marrow-nan-3m-Hematologic-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.27e-05 | 182 | 58 | 4 | e78ba2c5cae480c16a596ce7c3bf2d480becacf4 | |
| ToppCell | droplet-Marrow-nan-3m-Hematologic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.27e-05 | 182 | 58 | 4 | 1710eab3037a87609d21838be2d2d29c3bc36651 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 9.27e-05 | 182 | 58 | 4 | b427e43ee523a3ea9eca3207f3d82042f10f022a | |
| ToppCell | facs-GAT-Fat-24m-Lymphocytic|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.47e-05 | 183 | 58 | 4 | 377c2c6fcb2fd41396dd7a7a90e9d7ccafccf2f0 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Hematopoietic-T_cells-Treg|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.47e-05 | 183 | 58 | 4 | 450c30d2e389fcb17825394c27f9ccc4f33022e3 | |
| Drug | catechin; Up 200; 11uM; MCF7; HT_HG-U133A_EA | 5.40e-07 | 194 | 57 | 7 | 1101_UP | |
| Drug | Methantheline bromide [53-46-3]; Down 200; 9.6uM; MCF7; HT_HG-U133A | 8.44e-06 | 192 | 57 | 6 | 6254_DN | |
| Drug | alpha-estradiol; Down 200; 0.01uM; MCF7; HT_HG-U133A | 9.77e-06 | 197 | 57 | 6 | 6930_DN | |
| Drug | Glutethimide, para-amino [125-84-8]; Down 200; 17.2uM; MCF7; HT_HG-U133A | 9.77e-06 | 197 | 57 | 6 | 7463_DN | |
| Drug | Glipizide [29094-61-9]; Down 200; 9uM; MCF7; HT_HG-U133A | 9.77e-06 | 197 | 57 | 6 | 1508_DN | |
| Disease | male homosexuality | 9.48e-05 | 8 | 55 | 2 | EFO_0008486 | |
| Disease | age of onset of depressive disorder, wellbeing measurement | 1.52e-04 | 10 | 55 | 2 | EFO_0007869, OBA_2040166 | |
| Disease | wellbeing measurement, alcohol consumption measurement | 3.62e-04 | 74 | 55 | 3 | EFO_0007869, EFO_0007878 | |
| Disease | Immunologic Deficiency Syndromes | 8.42e-04 | 23 | 55 | 2 | C0021051 | |
| Disease | mental development measurement | 9.96e-04 | 25 | 55 | 2 | EFO_0008230 | |
| Disease | prostate carcinoma in situ (is_marker_for) | 1.25e-03 | 28 | 55 | 2 | DOID:8634 (is_marker_for) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| QDRDPRFSEIYHNIN | 551 | P27540 | |
| PNEHNNRIEAQENYI | 56 | Q7Z3E2 | |
| QPLKDREDDQYSHLQ | 161 | P09693 | |
| QYQKDAPDHQELNLD | 1281 | P01024 | |
| QYNTNALQRDAPHVE | 61 | Q15389 | |
| RPENDLYATQLNTHE | 41 | Q9NZA1 | |
| ENPLNFYHVNVEIED | 111 | Q9UN71 | |
| EVARQAQTSQEPYHD | 71 | Q9UJU2 | |
| VQDNGRNVHLQDEDY | 471 | Q8IZ07 | |
| LNTHNRNEPEYNISQ | 2291 | Q9Y618 | |
| ENQQFPDNESEEYHR | 456 | A5A3E0 | |
| QLQRDQEPDVHYDFE | 546 | Q92619 | |
| PALEYETLRQQQEEH | 5966 | Q03001 | |
| PDYQSHFRTIEELQQ | 141 | Q14532 | |
| VDLTQERDYLQAQHP | 211 | Q9P219 | |
| NFYNEHEEITNLTPQ | 216 | Q86XP3 | |
| VDEDELQPYTNRRQN | 321 | Q9UIS9 | |
| EYRIQEPNRENSFHS | 1041 | Q96Q89 | |
| ELNLQEYRQHPCAQD | 1196 | O75581 | |
| ENPLNFYHVNVEIED | 111 | Q9Y5G0 | |
| QEHLDYEIIQSLNPE | 336 | Q9H0A0 | |
| PQHQEQLRQQAHYDA | 471 | O00461 | |
| DEQDPQEVTYAQLDH | 291 | Q99706 | |
| ENQQFPDNESEEYHR | 456 | Q6S8J3 | |
| NDHPEITYRLRNDSN | 21 | Q9Y4D1 | |
| PVHQLNETIDYNEQF | 116 | Q1HG44 | |
| HSAENPETLDEIYNR | 1136 | Q13315 | |
| EQQYGSHEENLPADL | 321 | P36383 | |
| ANDHQHIRYNPLQDE | 26 | P07902 | |
| SEYSVPQDLNHELQE | 596 | Q8N3K9 | |
| PEQATELVHQLQEDY | 436 | Q7Z591 | |
| HLQAEPENHQYQQDL | 271 | Q7Z692 | |
| LEEPSKDYRENHNNN | 96 | Q9NW75 | |
| DNNYSTPNERGDHNR | 901 | O60716 | |
| HENQQFPNTEIEEYH | 381 | Q6S8J7 | |
| RAQDPDEGHNSIQNY | 156 | Q9Y5E1 | |
| NILDYIQPSTQDREH | 291 | P78332 | |
| NPSKRQEFEDYLHQE | 811 | A5PLK6 | |
| NLHAEPDYLEVLEQQ | 826 | Q9H5Y7 | |
| DDHLTQQYNEDRNPI | 566 | Q02383 | |
| TPDEEQNLNHYIQVL | 26 | Q6UW49 | |
| QYLRHEDEQALLDQN | 2666 | O75592 | |
| ENQQFPDNESEEYHR | 456 | P0CG38 | |
| TSRNRDNDPNDYVEQ | 131 | P19387 | |
| AANNAYRQQETEHIP | 551 | Q8TCG1 | |
| QDHDVRQSEFQQLPY | 1976 | A5YKK6 | |
| DQNTDVQYNRCDIPE | 286 | Q9H0M4 | |
| YQEDEEQTSTQPHRA | 676 | P61129 | |
| AQRREQEDLPLYQHQ | 1006 | Q8NI35 | |
| SDQVPSDQDAHQYLR | 21 | Q9H0U9 | |
| EENQEQPRNYSHHQL | 161 | Q14515 | |
| AHEDNLLPIQEDYSN | 116 | Q8TE23 | |
| HNEQQRIPFEESQYK | 316 | Q9UJW8 | |
| YEEHAREQEQQRQLS | 781 | Q9ULQ1 | |
| QLEALENDNFQDDPH | 31 | O43257 | |
| GQTPHDERQDSINAY | 531 | O60264 | |
| NALNSPLHQEYEENL | 316 | P16473 | |
| PDQNDVIHARQAYDL | 3121 | P20929 |